Where does NeuroLutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NeuroLutions, Inc. ranks #29,579 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NeuroLutions, Inc. hold?

NeuroLutions, Inc. holds 9 US utility patents granted between 2017 and 2025, spanning 8 technology areas.

What is NeuroLutions, Inc.'s Innovation Score?

NeuroLutions, Inc. has an Innovation Score of 49.5 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NeuroLutions, Inc. focus on?

NeuroLutions, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 9 patents. Grants appear in 8 CPC subclasses total.

Is NeuroLutions, Inc.'s patent grant rate increasing or decreasing?

NeuroLutions, Inc.'s recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for NeuroLutions, Inc.'s patents?

NeuroLutions, Inc.'s patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NeuroLutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NeuroLutions, Inc.

USPTO PatentsView assignee record - 9 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neurolutions ranks #29,579 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 8 technology areas.

#29,579
of 49,997 US assignees by volume: Top 14%
by Innovation Score (49.5/100): 19.3
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R29579 · US Corporation #29,579 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #29,579/49,997
PHOTO-FINISH Netclearance Systems
CPC-NARROW A61B · 8 areas
INNOV-PAR 49.5/100
CLAIMS-RICH 19.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Netclearance Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
NeuroLutions · this assignee

50
3D Lighting… · lowest

7

What this shows Neurolutions's Innovation Score is 49.5/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Neurolutions's grants concentrate

NeuroLutions, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2017. By volume, Neurolutions sits between NetTALK.com, Inc. and New Ideas Manufacturing LLC.

Neurolutions's three-year grant acceleration

NeuroLutions, Inc. shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nettalk com

9
Netclearance Syst…

9
Neuvector

9
Neuren Pharmaceut…

9
Neurovision Imagi…

9
Neurocentria

9
Neutron Therapeut…

9
New Ideas Manufac…

9
Neurolutions ◀

9

What this shows NeuroLutions holds 9 patents at rank #29,594, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NeuroLutions

By rank, the assignees closest to #29,594 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in NeuroLutions's primary technology class.

Neurolutions's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

NeuroLutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	11.1%
2019	1	11.1%
2022	2	22.2%
2023	1	11.1%
2024	2	22.2%
2025partial year	2	22.2%

Which technologies does NeuroLutions, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 9

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 6

G06F - Electric Digital Data Processing 5

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#29,579

of 49,997 tracked assignees

Innovation Score

49.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

NeuroLutions, Inc.'s patent record in context - here's where to go next.

NeuroLutions, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #29,579 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NeuroLutions, Inc. against NetTALK.com, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.